[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK25086A - Pharmaceutical formulation comprising beta-lactam antibiotics - Google Patents

Pharmaceutical formulation comprising beta-lactam antibiotics

Info

Publication number
HK25086A
HK25086A HK250/86A HK25086A HK25086A HK 25086 A HK25086 A HK 25086A HK 250/86 A HK250/86 A HK 250/86A HK 25086 A HK25086 A HK 25086A HK 25086 A HK25086 A HK 25086A
Authority
HK
Hong Kong
Prior art keywords
beta
pharmaceutical formulation
lactam antibiotics
lactam
antibiotics
Prior art date
Application number
HK250/86A
Other languages
English (en)
Inventor
Francis Walter Grimmett
Harry William Burnstead
Michael William Hartnell
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of HK25086A publication Critical patent/HK25086A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK250/86A 1981-12-02 1986-04-03 Pharmaceutical formulation comprising beta-lactam antibiotics HK25086A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8136295 1981-12-02

Publications (1)

Publication Number Publication Date
HK25086A true HK25086A (en) 1986-04-11

Family

ID=10526317

Family Applications (1)

Application Number Title Priority Date Filing Date
HK250/86A HK25086A (en) 1981-12-02 1986-04-03 Pharmaceutical formulation comprising beta-lactam antibiotics

Country Status (9)

Country Link
EP (1) EP0080862B1 (de)
JP (1) JPS58109419A (de)
AU (1) AU9103782A (de)
DE (1) DE3266580D1 (de)
ES (1) ES8401851A1 (de)
HK (1) HK25086A (de)
MY (1) MY8600479A (de)
NZ (1) NZ202657A (de)
ZA (1) ZA828797B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61210025A (ja) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk 安定化された抗生物質複合顆粒製剤
FR2594334B1 (fr) * 1986-02-20 1990-01-12 Bristol Myers Co Composition pharmaceutique injectable a base d'amoxicilline
IE880217L (en) * 1987-01-29 1988-07-29 Beecham Group Plc Potassium clavulanate
US5750685A (en) * 1987-01-29 1998-05-12 Smithkline Beecham, P.L.C. Process for preparing potassium clavulanate in rossette form
US5288861A (en) * 1987-01-29 1994-02-22 Beecham Group Plc Potassium clavulanate in rosette form
EP0281200B1 (de) * 1987-03-02 1994-01-19 Yamanouchi Europe B.V. Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung
US5211958A (en) * 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
DE68916983T2 (de) * 1988-02-25 1995-01-19 Yamanouchi Europ Bv Verfahren zur Herstellung eines pharmazeutischen Granulats.
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
GB9007945D0 (en) * 1990-04-07 1990-06-06 Beecham Group Plc Pharmaceutical formulation
US5670170A (en) * 1990-04-27 1997-09-23 Beecham Group P.L.C. Pharamaceutical formulation
RU2096955C1 (ru) * 1991-03-01 1997-11-27 Е.И.Дюпон Де Немур Энд Компани Вододиспергируемая гранулированная пестицидная композиция, получаемая методом экструзии, и способ ее получения
GB9114950D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
AU711441B2 (en) 1995-09-07 1999-10-14 Smithkline Beecham Plc Pharmaceutical formulation
CA2248179C (en) * 1996-02-29 2007-09-18 Fujisawa Pharmaceutical Co., Ltd. .beta.-lactam antibiotic-containing tablet and production thereof
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
TW474824B (en) 1996-09-13 2002-02-01 Basf Ag The production of solid pharmaceutical forms
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
AU5241200A (en) * 1999-06-29 2001-01-31 Miciopharma Chemical Aktiengesellschaft Retard formulation of amoxicillin for oral administration
AU2001292185A1 (en) 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AT413983B (de) * 2001-04-12 2006-08-15 Sandoz Ag K-clavulanat in der form eines granulates
AT412344B (de) * 2001-04-12 2005-01-25 Sandoz Ag Hydrophobisierte teilchen von k-clavulanat
US20060159741A1 (en) * 2002-11-26 2006-07-20 Janez Kerc Pharmaceutical compositions comprising amoxicillin and clavulanic acid
US8715734B2 (en) 2004-02-24 2014-05-06 Sandoz Ag Amoxicilline instant granulate
CN1767818A (zh) * 2004-05-31 2006-05-03 三亚药品株式会社 含β－内酰胺抗生素的分散片剂及其制备方法
KR100638315B1 (ko) * 2004-07-23 2006-10-25 주식회사 대웅제약 다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정
WO2014144407A1 (en) 2013-03-15 2014-09-18 Braintree Laboratories, Inc. Dual use oral pharmaceutical composition tablets of sulfate saltes and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1532993A (en) * 1975-03-07 1978-11-22 Beecham Group Ltd Injectable antibiotic compositions
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate

Also Published As

Publication number Publication date
EP0080862B1 (de) 1985-09-25
JPS58109419A (ja) 1983-06-29
DE3266580D1 (en) 1985-10-31
EP0080862A1 (de) 1983-06-08
NZ202657A (en) 1985-05-31
ES517868A0 (es) 1984-01-01
JPH026332B2 (de) 1990-02-08
AU9103782A (en) 1983-06-09
ES8401851A1 (es) 1984-01-01
MY8600479A (en) 1986-12-31
ZA828797B (en) 1983-09-28

Similar Documents

Publication Publication Date Title
DE3266580D1 (en) Pharmaceutical formulation comprising beta-lactam antibiotics
NZ193326A (en) Cephalosporin antibiotics and pharmaceutical compositions
GB2094309B (en) Cephalosporin antibiotics
DE3264782D1 (en) Medicinal formulation
NZ190559A (en) Cephalosporin antibiotics and pharmaceutical compositions
GB2106905B (en) Dioximino cephalosporin antibiotics
NZ194584A (en) -lactam antibiotics and pharmaceutical compositions
NZ201833A (en) Thieno-and furopyridinium-substituted cephalosporin derivatives and pharmaceutical compositions
NZ202033A (en) Pyrazinium-substituted cephalosporins and pharmaceutical compositions
AU8113282A (en) Beta-lactam antibiotics
GB8422453D0 (en) Pharmaceutical formulation
PT74365B (en) Beta-lactam antibiotics their preparation and use
GB8712240D0 (en) Pharmaceutical formulation
DE3273313D1 (en) Antibiotics
NZ190557A (en) Cephalosporin antibiotics and pharmaceutical compositions containing them
NZ190556A (en) Cephalosporin antibiotics and pharmaceutical compositions
ZA825707B (en) Beta-lactam antibiotics
GB8402574D0 (en) Pharmaceutical formulation
GB8301368D0 (en) Pharmaceutical formulation
GB8329594D0 (en) Pharmaceutical formulation
GB8308097D0 (en) Pharmaceutical formulation
GB8326645D0 (en) Pharmaceutical formulation
GB8304454D0 (en) Pharmaceutical formulation
GB8409705D0 (en) Pharmaceutical formulation
GB8425314D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)